This topic contains a solution. Click here to go to the answer

Author Question: Empathy can be described as: a. the ability to understand and share the feelings of another. b. ... (Read 229 times)

biggirl4568

  • Hero Member
  • *****
  • Posts: 551
Empathy can be described as:
 
  a. the ability to understand and share the feelings of another.
  b. feelings of pity and sorrow for someone else's misfortune.
  c. deep awareness of the suffering of another coupled with the wish to relieve it.
  d. a deep-seated dislike of something or someone.

Question 2

Specific profession-relevant directives or guidelines that reflect the best ethical practice of professionals are:
 
  a. privacy.
  b. ethical standards.
  c. principle ethics.
  d. virtue ethics.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Viet Thy

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

ANS: A

Answer to Question 2

ANS: B




biggirl4568

  • Member
  • Posts: 551
Reply 2 on: Jun 28, 2018
YES! Correct, THANKS for helping me on my review


vickyvicksss

  • Member
  • Posts: 351
Reply 3 on: Yesterday
Excellent

 

Did you know?

In women, pharmacodynamic differences include increased sensitivity to (and increased effectiveness of) beta-blockers, opioids, selective serotonin reuptake inhibitors, and typical antipsychotics.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

The highest suicide rate in the United States is among people ages 65 years and older. Almost 15% of people in this age group commit suicide every year.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library